1-8 of 8
Kartik Sehgal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT212: Elraglusib, a glycogen synthase kinase 3 beta (GSK 3β) inhibitor, plus chemotherapy with or without immunotherapy for advanced salivary gland cancer

Free
Glenn J. Hanna, Nicole Scarfo, Kee-Young Shin, Anne ONeill, Michael J. Dennis, Kartik Sehgal, Veronica Bedard, Andrew Mazar, Andrey Ugolkov, Robert I. Haddad
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_2): CT212.
https://doi.org/10.1158/1538-7445.AM2025-CT212
Published: 25 April 2025
View article titled, Abstract CT212: Elraglusib, a glycogen synthase kinase 3 beta (GSK 3β) inhibitor, plus chemotherapy with or without immunotherapy for advanced salivary gland cancer
Journal Articles

Abstract 6410: Blood DNA methylation in association with immune checkpoint inhibitor related outcomes among patients with head and neck squamous cell carcinoma

Free
Gyeyoon Yim, Lucas Salas, Kartik Sehgal, Keisuke Shirai, Rondi Butler, Julianna Miller, Hannah Stolrow, Md Saiful Islam Saif, Devin Koestler, John Wiencke, Robert Haddad, Karl Kelsey, Brock Christensen
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6410.
https://doi.org/10.1158/1538-7445.AM2025-6410
Published: 21 April 2025
View article titled, Abstract 6410: Blood DNA methylation in association with immune checkpoint inhibitor related outcomes among patients with head and neck squamous cell carcinoma
Journal Articles

Abstract 5795: Dynamic proteomic biomarkers of survival outcomes with anti-PD-1 immunotherapy in head and neck squamous cell carcinoma

Free
Md Saiful Islam Sai, Kartik Sehgal, Ze Zhang, Rondi Butler, John Wiencke, Annette Molinaro, Juliana Miller, Hannah Stolrow, Keisuke Shirai, Lucas Salas, Devin Kosetler, Robert Haddad, Brock C. Christensen, Karl Kelsey
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 5795.
https://doi.org/10.1158/1538-7445.AM2025-5795
Published: 21 April 2025
View article titled, Abstract 5795: Dynamic proteomic biomarkers of survival outcomes with anti-PD-1 immunotherapy in head and neck squamous cell carcinoma
Journal Articles

Abstract A004: Blood DNA methylation in association with immune checkpoint inhibitor related outcomes among patients with head and neck squamous cell carcinoma

Free
Gyeyoon Yim, Lucas Salas, Kartik Sehgal, Keisuke Shirai, Rondi Butler, Julianna Miller, Hannah Stolrow, Md Saiful Islam Saif, Devin Koestler, John Wiencke, Robert Haddad, Karl Kelsey, Brock Christensen
Journal: Cancer Research
Cancer Res (2025) 85 (3_Supplement): A004.
https://doi.org/10.1158/1538-7445.DNAMETHYLATION-A004
Published: 01 February 2025
View article titled, Abstract A004: Blood DNA methylation in association with immune checkpoint inhibitor related outcomes among patients with head and neck squamous cell carcinoma
Journal Articles

Abstract CT183: Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132)

Free
Benjamin Izar, Dmitriy Zamarin, David R. Spigel, Christopher J. Hoimes, David F. McDermott, Kartik Sehgal, Yana G. Najjar, Adam J. Schoenfeld, Edward B. Garon, Ryan J. Sullivan, Brian S. Henick, Ticiana A. Leal, Michael E. Hurwitz, Rana R. McKay, Natalie Busby, Anita Mehta-Damani, Alex Azrilevich, Tony Tran, Naiyer Rizvi, Martin Oft, Alexander I. Spira
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT183.
https://doi.org/10.1158/1538-7445.AM2024-CT183
Published: 05 April 2024
View article titled, Abstract CT183: Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132)
Journal Articles

Abstract CT099: NGM707 in combination with pembrolizumab in advanced or metastatic solid tumors: Preliminary results from dose escalation

Free
Judy S. Wang, Manish R. Sharma, William J. Edenfield, Kartik Sehgal, Do-Youn Oh, Yixing Jiang, Joel Michalski, Jeeyun Lee, Hans Hammers, Li-Yuan Bai, Chih-Hung Hsu, Brenda Dampier, Kefei Zhou, Li Yan, Lisa K. Blum, Joanne Sloan-Lancaster, Daniel D. Kaplan, Dhiraj Abhyankar, Hsiao D. Lieu, Vladimir Hanes, Aung Naing
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT099.
https://doi.org/10.1158/1538-7445.AM2024-CT099
Published: 05 April 2024
View article titled, Abstract CT099: NGM707 in combination with pembrolizumab in advanced or metastatic solid tumors: Preliminary results from dose escalation
Journal Articles

Clonal Selection Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma

Free
Kartik Sehgal, David A. Barbie
Journal: Cancer Research
Cancer Res (2019) 79 (23): 5915–5916.
https://doi.org/10.1158/0008-5472.CAN-19-2937
Published: 02 December 2019
View article titled, Clonal Selection Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma
Open the PDF for Clonal Selection Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma in another window
Journal Articles

Abstract 1354: Comparison of pomalidomide dosing strategies in lenalidomide-refractory myeloma: Impact on clinical outcome, immune activation and cereblon targets

Free
Rituparna Das, Kartik Sehgal, Lin Zhang, Rakesh Verma, Yanhong Deng, Mehmet Kocoglu, Juan Vasquez, Srini Koduru, Yan Ren, Maria Wang, Suzana Couto, Mike Breider, Donna Hansel, Stuart Seropian, Dennis Cooper, Anjan Thakurta, Xiaopan Yao, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1354.
https://doi.org/10.1158/1538-7445.AM2015-1354
Published: 01 August 2015
View article titled, Abstract 1354: Comparison of pomalidomide dosing strategies in lenalidomide-refractory myeloma: Impact on clinical outcome, immune activation and cereblon targets